Vyalev
Active substance: FOSCARBIDOPA, FOSLEVODOPA
INJECTION · FOSCARBIDOPA 12 mg/mL, FOSLEVODOPA 240 mg/mL
United StatesActive
Marketing holder: AbbVie Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- FOSCARBIDOPA · 12 mg/mL
- FOSLEVODOPA · 240 mg/mL
Registration
- Registration number
- 0074-0501
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0074-0501 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0074-0501 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0074-0501 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0074-0501 · Verified 2026-10-09 · open in source